Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Is there an optimal prophylactic nitrate therapy?

G Olsson1, J Allgén

  • 1Department of Medicine, Cardiovascular Research, AB Hässle, Mölndal, Sweden.

European Heart Journal
|May 1, 1991
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Aristotle wires for cannulating target vessels in paediatric neuro-interventional procedures: A case-control study.

The neuroradiology journal·2025
Same author

Opportunities and challenges of tackling Scope 3 "Indirect" emissions from residential hot water.

Water research X·2023
Same author

Exposure to Low to Moderate Doses of Ionizing Radiation Induces A Reduction of Pro-Inflammatory Ly6chigh Monocytes and a U-Curved Response of T Cells in APOE -/- Mice.

Dose-response : a publication of International Hormesis Society·2021
Same author

Epilepsy in patients with primary brain tumors: The impact on mood, cognition, and HRQOL.

Epilepsy & behavior : E&B·2015
Same author

Instrumentation, control and automation in wastewater--from London 1973 to Narbonne 2013.

Water science and technology : a journal of the International Association on Water Pollution Research·2014
Same author

Aeration control - a review.

Water science and technology : a journal of the International Association on Water Pollution Research·2013
Same journal

The surgical collateralization theory: has the beautiful hypothesis been killed by the ugly facts?

European heart journal·2026
Same journal

Beyond single measurement: additional considerations for high-sensitivity C-reactive protein in cardiovascular risk prediction.

European heart journal·2026
Same journal

Brain mineralocorticoid receptor activation and antagonism in heart failure with preserved ejection fraction: a hypothesis.

European heart journal·2026
Same journal

Myths and misconceptions about high-sensitivity C-reactive protein as a marker of residual inflammatory risk.

European heart journal·2026
Same journal

Vascular Ehlers-Danlos syndrome: should we treat asymptomatic patients?

European heart journal·2026
Same journal

Impactful trials on dyslipidaemias, fractional flow reserve, beta-blockers, and peripheral artery disease.

European heart journal·2026
See all related articles

Controlled-release nitrate formulations offer a solution to common treatment issues for angina pectoris. These formulations aim to improve nitrate absorption and duration, potentially preventing tolerance and rebound effects with convenient dosing.

Area of Science:

  • Cardiology
  • Pharmacology

Background:

  • Nitrates are established for angina pectoris prophylaxis.
  • Practical issues include variable absorption, short action, headache, tolerance, and rebound phenomena.

Purpose of the Study:

  • To discuss formulation strategies for overcoming practical challenges with nitrate therapy.
  • To explore how controlled-release formulations can mitigate adverse effects and improve patient compliance.

Main Methods:

  • Review of existing literature on nitrate formulations and their clinical implications.
  • Discussion of controlled-release systems designed to maintain therapeutic nitrate levels.

Main Results:

  • Controlled-release formulations can achieve sufficient plasma concentrations for efficacy.

Related Experiment Videos

  • Maintaining low, rather than zero, nitrate levels may prevent tolerance and rebound.
  • Conclusions:

    • Optimized nitrate formulation, specifically controlled-release systems, can address issues like tolerance and rebound.
    • A once-daily, controlled-release regimen offers prolonged action and improved patient convenience.